Cannabis Law Report

OCTOBER 1, 2021

Epoladerm™ is a topical diclofenac metered-dose spray film formulation being developed to manage acute musculoskeletal pain and osteoarthritis. In 2005, Noble established NobleCon, an investor conference that has grown substantially over the 16 years. For more information, please visit www.virpaxpharma.com.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Cannabis Law Report

JULY 12, 2019

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. Lancet Neurol Dec 23 2015.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Green Relief

FEBRUARY 20, 2018

I was first introduced to the topic of Epigenetics in 2008 at a business conference in Florida, and as a medical professional I was immediately intrigued. 2005;(168):385-423. 10/8/2017. 0 COMMENTS. By Janna Champagne, BSN, RN. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors. DiForti, M.,

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52